byiShook Opinion
Oct 14, 2024 - 18:00
Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide. The post Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug appeared first on Investor's Business Daily.
Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.
The post Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug appeared first on Investor's Business Daily.